| [1] | Bahn Chair RS, Burch H. B., Cooper D. S., Garber J. R., Greenlee M. C., Klein I., et al. 2011. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists". Thyroid. 21 (6): 593–646. doi:10.1089/thy.2010.0417. PMID 21510801. |
| [2] | Andersson M., Zimmermann M. B. 2010. "Influence of Iodine Deficiency and Excess on Thyroid Function Tests". Thyroid Function Testing. Endocrine Updates. 28: 45–69. doi:10.1007/978-1-4419-1485-9_3. ISBN 978-1-4419-1484-2. ISSN 1566-0729. |
| [3] | Bains, A., Brosseau A. J., Harrison D. 2015."Iatrogenic thyrotoxicosis secondary to compounded liothyronine". The Canadian Journal of Hospital Pharmacy. 68 (1): 57–9. doi:10.4212/cjhp.v68i1.1426. PMC 4350501. PMID 25762821. |
| [4] | Floyd J. L. (21 March 2017) [2009]. "Thyrotoxicosis". eMedicine. Archived from the original on 17 March 2010. |
| [5] | Weiss R. E., Refetoff S. 2011. Thyrotropin (TSH)-secreting pituitary adenomas, Last literature review version 19.1: January 2011. |
| [6] | Devereaux D., Tewelde SZ. 2014. Hyperthyroidism and thyrotoxicosis, Emergency Medicine Clinics of North America. 32 (2): 277–292. doi:10.1016/j.emc.2013.12.001. PMID 24766932. |
| [7] | Hypothyroidism-Diagnosis and treatment-Mayo Clinic". www.mayoclinic.org. Retrieved 6 May 2021. |
| [8] | Ross D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L. et al. 2016. "2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis". Thyroid. 26 (10): 1343–1421. doi:10.1089/thy.2016.0229. PMID 27521067. |
| [9] | Czarnywojtek, A., Owecki, M., Zgorzalewicz-Stachowiak, Kosma Woliński, et al. 2014. The Role of Serum C-Reactive Protein Measured by High-Sensitive Method in Thyroid Disease, Arch Immunol Ther Exp (Warsz). 62(6): 501–509. doi: 10.1007/s00005-014-0282-1. |
| [10] | Nagasaki T, Inaba M, Shirakawa K, et al. Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomed Pharmacother. 2007; 61: 167–172. doi: 10.1016/j.biopha.2006.10.008. |
| [11] | Al-Odat, I., Al-Fawaeir, S., Al-Mahmoud, M. H. 2024. Study of the association between thyroid dysfunction and serum lipid abnormalities, Biomedical Reports logo; 21(4): 138.doi: 10.3892/br.2024.1826. |
| [12] | Kaneko, J. J., Harvey, J. W. and Bruss, M. L. (2008). Clinical biochemistry of domestic animals, Academic, press. https://books.google.iq/books. |
| [13] | Dixit, A., M. N. Khatib, S. Gaidhane, A. M. Gaidhane and Q. S. Zahiruddin (2020). "Assessment of serum lipid profile in patients with thyroid disorders in a rural backdrop of central India." Medical Science 24 (101): 1-11. https://mail.discoveryjournals.org/medicalscience/current_issue/v24/n101/A1.pdf. |
| [14] | Khan, F. A., S. Patil, A. S. Thakur, M. F. Khan and K. Murugan (2014). "Lipid Profile in Thyroid Dysfunction: A Study on Patients of Bastar Tiroid Fonksiyon Bozukluğu Lipid Profili: Bastar’da Hastalar Üzerine BirÇalışma." TC322 (51.19a): 155. 185-127. 175b. https://www.researchgate.net/profile/Farah-Khan-. |
| [15] | Khinteel Jabbar, N., Z. Al-Abady, A. Jasib ThaabanAlmzail and R. Al-Athary (2022). "Relationship between Menopause and Complications of Hyperthyroidism in Female Patients in Iraq." Archives of Razi Institute 77(4): 14811489. https://doi.org/10.22092/ari.2022.357618.2071. |
| [16] | Perros, P., C. Van Der Feltz‐Cornelis, E. Papini, E. V. Nagy, A. P. Weetman and L. J. C. e. Hegedüs (2021). "The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: a narrative review. https://doi.org/10.1111/cen.14473. |
| [17] | Leng, O. and Razvi, S. J. T. r. (2019). "Hypothyroidism in the older population." 12(1): 1-10. https://doi.org/10.1186/s13044-019-0063-3. |
| [18] | Fiore, E. and P. Vitti (2012). "Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease." The Journal of Clinical Endocrinology & Metabolism 97(4): 1134-1145. https://doi.org/10.1210/jc.2011-2735. |
| [19] | Forman, H. J., O. Augusto, R. Brigelius-Flohe, P. A. Dennery, B. Kalyanaraman, H. Ischiropoulos, G. E. Mann, R. Radi, L. J. Roberts II and J. Vina (2015). "Even free radicals should follow some rules: a guide to free radical research terminology and methodology." Free Radical Biology and Medicine 78: 233-235. https://doi.org/10.1016/j.freeradbiomed.2014.10.504. |
| [20] | Stanley, J., R. Neelamohan, E. Suthagar, G. Vengatesh, J. Jayakumar, M. Chandrasekaran, S. Banu and M. Aruldhas (2016). "Lipid peroxidation and antioxidants status in human malignant and non-malignant thyroid tumours." Human & Experimental Toxicology 35(6): 585-597. https://doi.org/10.1177/0960327115597982. |
| [21] | Petrulea, M., A. Muresan and I. Duncea (2012). "Oxidative stress and antioxidant status in hypo-and hyperthyroidism." Antioxidant enzyme 8: 197-236. https://doi.org/10.5772/51018. |
| [22] | Garbern, J. C. and R. T. Lee (2021). "Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes." Stem Cell Research & Therapy 12(1): 1-25. https://doi.org/10.1186/s13287-021-02252-6. |
| [23] | Alturfan, A., E. Zengin, N. Dariyerli, E. Alturfan, M. Gumustas, E. Aytac, M. Aslan, N. Balkis, A. Aksu and G. Yigit (2007). "Investigation of zinc and copper levels in methimazole-induced hypothyroidism: relation with the oxidant-antioxidant status." Folia Biologica 53(5): 183-188. https://doi.org/10.14712/fb2007053050183. |
| [24] | Marcocci, C., M. Leo and M. A. Altea (2012). "Oxidative stress in graves’ disease." European Thyroid Journal 1(2): 80-87. https://doi.org/10.1159/000337976. |
| [25] | Erem, C., Suleyman, A. K., Civan, N., Mentese, A., et al. 2015. Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress, Endocrine Journal, 62 (6): 493-501. |
| [26] | Witko-Sarsat, V., M. Friedlander, C. Capeillère-Blandin, T. Nguyen-Khoa, A. T. Nguyen, J. Zingraff, P. Jungers and B. Descamps-Latscha (1996). "Advanced oxidation protein products as a novel marker of oxidative stress in uremia." Kidney international 49(5): 1304-1313. https://doi.org/10.1038/ki.1996.186. |
| [27] | Cakatay, U. (2005). "Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control." Diabetes & metabolism 31(6): 551-557. https://doi.org/10.1016/S1262-3636(07)70230-6. |
| [28] | Capelli, V., C. Diéguez, J. Mittag and M. López (2021). "Thyroid wars: The rise of central actions." Trends in Endocrinology & Metabolism 32(9): 659-671. https://doi.org/10.1016/j.tem.2021.05.006. |
| [29] | Goswami, K., D. N. Nandakumar, B. C. Koner, Z. Bobby and S. K. Sen (2003). "Oxidative changes and desialylation of serum proteins in hyperthyroidism." Clinicachimica acta 337(1-2): 163-168. https://doi.org/10.1016/S0009-8981(03)00186-7. |
| [30] | Messarah, M., A. Boumendjel, A. Chouabia, F. Klibet, C. Abdennour, M. S. Boulakoud and A. El Feki (2010). "Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats." Experimental and Toxicologic Pathology 62(3): 301-310. https://doi.org/10.1016/j.etp.2009.04.009. |
| [31] | Takeda, I. and T. Kometani (1981). "Emergency laboratory service in Shimane Prefectural Central Hospital (author's transl)." Rinshobyori. The Japanese journal of clinical pathology 29(1): 37-41 https://doi.org/10.11477/mf.1436201531. |
| [32] | Thompson, S., C. Fechtrup, E. Squire, U. Heyse, G. Breithardt, J. Van de Loo and J. Kienast (1996). "Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris." Arteriosclerosis, thrombosis, and vascular biology 16(3): 357-362. https://doi.org/10.1161/01.ATV.16.3.357. |
| [33] | Anderson, J. L., J. F. Carlquist, J. B. Muhlestein, B. D. Horne and S. P. Elmer (1998). "Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction." Journal of the American College of Cardiology 32(1): 35-41. https://doi.org/10.1016/S0735-1097(98)00203-4. |
| [34] | Mendall, M., P. Patel, L. Ballam, D. Strachan and T. Northfield (1996). "C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study." Bmj312 (7038): 1061-1065. https://doi.org/10.1136/bmj.312.7038.1061. |
| [35] | Toss, H., B. Lindahl, A. Siegbahn, L. Wallentin and f. t. F. S. Group (1997). "Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease." Circulation 96(12): 4204-4210. https://doi.org/10.1161/01.CIR.96.12.4204. |
| [36] | Pasceri, V.; Willerson, J. T.; Edward T. H. Yeh, T. H.E.; 2000. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells, Circulation, 102: 2165-2168. is available at http://www.circulationaha.org. |